Printer Friendly

Global Physician Dispensed Cosmeceuticals Industry.

NEW YORK, Sept. 6, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

http://www.reportlinker.com/p0960404/Global-Physician-Dispensed-Cosmeceuticals-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Skin_Care_Products

This report analyzes the worldwide markets for Physician Dispensed Cosmeceuticals in US$ Million by the following major Product Segments: Physician Dispensed Skin Care Products, and Physician Dispensed Eyelash Products. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. The report profiles 73 companies including many key and niche players such as Allergan, Inc., Athena Cosmetics, Inc., Jan Marini Skin Research, Inc., Biopelle, Inc., Candem Pharma, Inc., Clinique Laboratories, LLC, exCel Manufacturing Co., Inc., Histogen, Inc., La Roche-Posay Laboratoire Pharmaceutique, Neutrogena Corporation, Obagi Medical Products, Inc., Pacific Bioscience Laboratories, Inc., SkinCeuticals, SkinMedica, Inc., Solta Medical, Inc., and Stiefel Laboratories, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONSStudy Reliability and Reporting Limitations I-1Disclaimers I-2Data Interpretation & Reporting Level I-2Quantitative Techniques & Analytics I-3Product Definitions and Scope of Study I-3Physician Dispensed Skin Care Products I-3Physician Dispensed Eyelash Products I-3II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW II-1

Physician Dispensed Cosmeceuticals: A Prelude II-1

Cosmeceuticals Market Remains Unscathed by Economical Woes II-1

Current and Future Analysis II-2

Market Dynamics II-2

Cosmeceutical Consumers: A Highly Informed Group II-2

The Mid-Life Crisis - A Key Growth Driver II-3

Women Account for Highest Spends on Skin Care II-3

Customizing Solutions for Uninsured Patients to go a Long Way II-4

Post Procedure Topical Products in Demand II-4

Physician Dispensing Outsmarts Conventional Retail Brands II-4

Manufacturers Widen Customer Base II-4

Innovative Ingredients Gain Focus II-5

Natural Ingredients Gain Attention II-5

What's Next in Ingredients II-6

Possible Ban on Hydroquinone Stimulates Search for Other

Pigment Control Products II-6

Skin Brightening and Lightening Products - A High Growth Market II-6

Companies Focus on Complementary Products II-7

Distribution Scenario II-7

E-Commerce to Reinforce Sales of Physician Dispensed Products II-8

Social Networking - A New Marketing Tool II-8

Competition II-8

Table 1: Leading Players in the Global Physician-Dispensed

Topical Skincare Products Eyelash Products (2010): Percentage

Breakdown of Revenues for Allergan Medical, Obagi,

SkinMedica, Skinceuticals, and Others (includes corresponding

Graph/Chart) II-9

Table 2: Leading Players in the Global Physician-DispensedEyelash Products (2010): Percentage Breakdown of Revenues forAllergan Medical, Athena Cosmetics, La Canada Ventures, andOthers (includes corresponding Graph/Chart) II-9

2. AESTHETICS MARKET: A BRIEF INSIGHT II-10

Historical and Recent Past Perspective II-10

Current Scenario, Outlook II-11

Aging Population: A Weighty Demographic Driver II-11

Societal Pressure to Look Young Peps Demand for Facial Aesthetics II-12

Undesirable Side Effects: A Challenge to Reckon With II-12

3. PRODUCT OVERVIEW II-13Introduction to Cosmeceuticals II-13Physician Dispensed Cosmeceuticals II-13Physician Dispensed Eyelash Products II-13Physician Dispensed Skin Care Products II-13Skin Care Products - An Overview II-13Moisturizers II-13Nourishers/Anti-Agers II-14Facial Cleansers II-14Sun Care Products II-14An Insight into Key Ingredients II-14Antioxidants II-14Hydroxy Acids (poly, beta, alpha) II-15Lightening Agents II-15Botanicals/ Plant Extracts II-15Proteins/Peptides II-15OTC Retinoids II-15Niacinamide II-15Topical Peptides II-15N-Acetyl Glucosamine II-16Competitive Aesthetic Procedures: Bulk Dermal Heating II-16Tissue Tightening Procedure using RF II-16BILD Procedure II-16

4. AN INSIGHT INTO THE MARKET BARRIERS II-17

Debate Surrounding Physician Dispensing of Cosmeceuticals II-17

Ethical Perspective II-17

Cost Related Issues II-17

Product Efficacy II-17

Emergence of Medispas II-18

Patient Discretion and Requirement II-18

Merits of Physician Dispensing II-18

Challenges II-19

5. RECENT INDUSTRY ACTIVITY II-20L'Oreal USA Acquires Pacific Bioscience Laboratories II-20Sanofi-Aventis Canada to Acquire Assets of Canderm Pharma II-20Solta Medical Acquires Aesthera II-20Biopelle Takes Over PRESCRIBEDsolutions II-21Neutraderm Enters into Distribute Deal for Dr. Susan Taylor'sRx for Brown Skin Product Line II-21

6. PRODUCT LAUNCHES II-22

Obagi Medical Products Launches Nu-Derm Sun Shield SPF 50 And

Blue Peel RADIANCE (TM) II-22

GSK's Stiefel Launches REVALESKIN HydraLift Complex Anti-

Aging Formula II-22

SkinMedica Introduces Biometa Essential SerumTM Anti-Aging

Solution II-22

SkinMedica Introduces Redness Relief CalmPlexTM Anti-Redness

Solution II-22

SkinMedica Rolls Out Tri-Retinol Complex ESTM Anti-Aging Cream II-23

Obagi Medical Products Launches ELASTILashTM Eyelash

Enhancement Solution II-23

Pacific Bioscience Laboratories Unveils Clarisonic in Various

Regions II-23

Reliant Technologies Unveils Fraxel Skin Ecology System II-24

Pacific Bioscience Laboratories Launches Opal Sonic Infusion II-24

Timeless Skin Solutions Launches Latisse II-24

7. FOCUS ON SELECT GLOBAL PLAYERS II-25Allergan, Inc. (The US) II-25Athena Cosmetics, Inc. (The US) II-26Jan Marini Skin Research, Inc. (The US) II-26Biopelle, Inc. (The US) II-26Candem Pharma, Inc. (Canada) II-26Clinique Laboratories, LLC (The US) II-27exCel Manufacturing Co., Inc. (The US) II-27Histogen, Inc. (The US) II-27La Roche-Posay Laboratoire Pharmaceutique (France) II-28Neutrogena Corporation (The US) II-28Obagi Medical Products, Inc. (The US) II-28Pacific Bioscience Laboratories, Inc. (The US) II-29SkinCeuticals (The US) II-29SkinMedica, Inc. (The US) II-29Solta Medical, Inc. (The US) II-30Stiefel Laboratories, Inc. (The US) II-30

8. GLOBAL MARKET PERSPECTIVE II-31

Table 3: World Recent Past, Present and Future Analysis for

Physician Dispensed Cosmeceuticals by Geographic Region - US,

Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of

World Markets Independently Analyzed with Annual Sales Figures

in US$ Million for the Years 2010 through 2018 (includes

corresponding Graph/Chart) II-31

Table 4: World Historic Review for Physician DispensedCosmeceuticals by Geographic Region - US, Canada, Japan,Europe, Asia-Pacific, Latin America and Rest of World MarketsIndependently Analyzed with Annual Sales Figures in US$Million for the Years 2004 through 2009 (includescorresponding Graph/Chart) II-32

Table 5: World 15-Year Perspective for Physician Dispensed

Cosmeceuticals by Geographic Region - Percentage Breakdown of

Value Sales for - US, Canada, Japan, Europe, Asia-Pacific,

Latin America and Rest of World Markets for the Years 2004,

2011 and 2018 (includes corresponding Graph/Chart) II-33

By Product Segment II-34

Table 6: World Recent Past, Present and Future Analysis for

Physician Dispensed Skin Care Products by Geographic Region -

US, Canada, Japan, Europe, Asia-Pacific, Latin America and

Rest of World Markets Independently Analyzed with Annual Sales

Figures in US$ Million for the Years 2010 through 2018

(includes corresponding Graph/Chart) II-34

Table 7: World Historic Review for Physician Dispensed SkinCare Products by Geographic Region - US, Canada, Japan,Europe, Asia-Pacific, Latin America and Rest of World MarketsIndependently Analyzed with Annual Sales Figures in US$Million for the Years 2004 through 2009 (includescorresponding Graph/Chart) II-35

Table 8: World Recent Past, Present and Future Analysis for

Physician Dispensed Eyelash Products by Geographic Region -

US, Canada, Japan, Europe, Asia-Pacific, Latin America and

Rest of World Markets Independently Analyzed with Annual Sales

Figures in US$ Million for the Years 2010 through 2018

(includes corresponding Graph/Chart) II-36

Table 9: World Historic Review for Physician Dispensed EyelashProducts by Geographic Region - US, Canada, Japan, Europe,Asia-Pacific, Latin America and Rest of World MarketsIndependently Analyzed with Annual Sales Figures in US$Million for the Years 2004 through 2009 (includescorresponding Graph/Chart) II-37

Table 10: World 15-Year Perspective for Physician Dispensed

Skin Care Products by Geographic Region - Percentage Breakdown

of Value Sales for - US, Canada, Japan, Europe, Asia-Pacific,

Latin America and Rest of World Markets for the Years 2004,

2011 and 2018 (includes corresponding Graph/Chart) II-38

Table 11: World 15-Year Perspective for Physician DispensedEyelash Products by Geographic Region - Percentage Breakdownof Value Sales for - US, Canada, Japan, Europe, Asia-Pacific,Latin America and Rest of World Markets for the Years 2004,2011 and 2018 (includes corresponding Graph/Chart) II-39III. MARKET

1. THE UNITED STATES III-1

A.Market Analysis III-1

Current and Future Analysis III-1

Physician-Dispensed Cosmeceuticals Market: Overview III-1

Competition III-1

US Aesthetics Market III-2

Major Trends III-2

FDA to Completely Ban Usage of Hydroquinone in Pigment

Controlling Products III-2

Ingredients for Skin Lightening Witness Surging Demand III-3

Strategic Corporate Developments III-3

Product Launches III-5

B.Market Analytics III-7

Table 12: US Recent Past, Current and Future Analysis for

Physician Dispensed Cosmeceuticals by Product Segment-

Eyelash Products and Skin Care Products Independently

Analyzed with Annual Sales Figures in US$ Million for the

Years 2010 through 2018 (includes corresponding Graph/Chart) III-7

Table 13: US Historic Review for Physician DispensedCosmeceuticals by Product Segment- Eyelash Products and SkinCare Products Independently Analyzed with Annual SalesFigures in US$ Million for the Years 2004 through 2009(includes corresponding Graph/Chart) III-8

Table 14: US 15-Year Perspective for Physician Dispensed

Cosmeceuticals by Product Segment - Percentage Breakdown of

Value Sales for Eyelash Products and Skin Care Products for

the Years 2004, 2011 and 2018 (includes corresponding

Graph/Chart) III-9

2. CANADA III-10A.Market Analysis III-10Outlook III-10Anti-Aging Products Market III-10B.Market Analytics III-11Table 15: Canadian Recent Past, Current and Future Analysisfor Physician Dispensed Cosmeceuticals by Product Segment-Eyelash Products and Skin Care Products IndependentlyAnalyzed with Annual Sales Figures in US$ Million for theYears 2010 through 2018 (includes corresponding Graph/Chart) III-11

Table 16: Canadian Historic Review for Physician Dispensed

Cosmeceuticals by Product Segment- Eyelash Products and Skin

Care Products Independently Analyzed with Annual Sales

Figures in US$ Million for the Years 2004 through 2009

(includes corresponding Graph/Chart) III-12

Table 17: Canadian 15-Year Perspective for PhysicianDispensed Cosmeceuticals by Product Segment - PercentageBreakdown of Value Sales for - Eyelash Products and SkinCare Products for the Years 2004, 2011 and 2018 (includescorresponding Graph/Chart) III-13

3. JAPAN III-14

A.Market Analysis III-14

Measuring the Potential of Anti-Ageing Products III-14

B.Market Analytics III-15

Table 18: Japanese Recent Past, Current and Future Analysis

for Physician Dispensed Cosmeceuticals by Product Segment-

Eyelash Products and Skin Care Products Independently

Analyzed with Annual Sales Figures in US$ Million for the

Years 2010 through 2018 (includes corresponding Graph/Chart) III-15

Table 19: Japanese Historic Review for Physician DispensedCosmeceuticals by Product Segment- Eyelash Products and SkinCare Products Independently Analyzed with Annual SalesFigures in US$ Million for the Years 2004 through 2009(includes corresponding Graph/Chart) III-16

Table 20: Japanese 15-Year Perspective for Physician

Dispensed Cosmeceuticals by Product Segment - Percentage

Breakdown of Value Sales for - Eyelash Products and Skin

Care Products for the Years 2004, 2011 and 2018 (includes

corresponding Graph/Chart) III-17

4. EUROPE III-18A.Market Analysis III-18Outlook III-18Skin Care market in Europe III-18B.Market Analytics III-19Table 21: European Recent Past, Present and Future Analysisfor Physician Dispensed Cosmeceuticals by Product Segment-Eyelash Products and Skin Care Products IndependentlyAnalyzed with Annual Sales Figures in US$ Million for theYears 2010 through 2018 (includes corresponding Graph/Chart) III-19

Table 22: European Historic Review for Physician Dispensed

Cosmeceuticals by Product Segment- Eyelash Products and Skin

Care Products Independently Analyzed with Annual Sales

Figures in US$ Million for the Years 2004 through 2009

(includes corresponding Graph/Chart) III-20

Table 23: European 15-Year Perspective for PhysicianDispensed Cosmeceuticals by Product Segment - PercentageBreakdown of Value Sales for Eyelash Products and Skin CareProducts for the Years 2004, 2011 and 2018 (includescorresponding Graph/Chart) III-21

5. ASIA-PACIFIC III-22

A.Market Analysis III-22

Current and Future Analysis III-22

Asian Aesthetics Market III-22

B.Market Analytics III-24

Table 24: Asia-Pacific Recent Past, Present and Future

Analysis for Physician Dispensed Cosmeceuticals by

Geographic Region - China, India and Rest of Asia-Pacific

Markets Independently Analyzed with Annual Sales Figures in

US$ Million for the Years 2010 through 2018 (includes

corresponding Graph/Chart) III-24

Table 25: Asia-Pacific Historic Review for PhysicianDispensed Cosmeceuticals by Geographic Region - China, Indiaand Rest of Asia-Pacific Markets Independently Analyzed withAnnual Sales Figures in US$ Million for the Years 2004through 2009 (includes corresponding Graph/Chart) III-25

Table 26: Asia-Pacific Recent Past, Present and Future

Analysis for Physician Dispensed Cosmeceuticals by Product

Segment- Eyelash Products and Skin Care Products

Independently Analyzed with Annual Sales Figures in US$

Million for the Years 2010 through 2018 (includes

corresponding Graph/Chart) III-26

Table 27: Asia-Pacific Historic Review for PhysicianDispensed Cosmeceuticals by Product Segment- EyelashProducts and Skin Care Products Independently Analyzed withAnnual Sales Figures in US$ Million for the Years 2004through 2009 (includes corresponding Graph/Chart) III-27

Table 28: Asia-Pacific 15-Year Perspective for Physician

Dispensed Cosmeceuticals by Geographic Region - Percentage

Breakdown of Value Sales for - China, India and Rest of

Asia-Pacific Markets for the Years 2004, 2011 and 2018

(includes corresponding Graph/Chart) III-28

Table 29: Asia-Pacific 15-Year Perspective for PhysicianDispensed Cosmeceuticals by Product Segment- PercentageBreakdown of Value Sales for Eyelash Products and Skin CareProducts for the Years 2004, 2011 and 2018 (includescorresponding Graph/Chart) III-29

5a. CHINA III-30

Market Analysis III-30

Table 30: Chinese Recent Past, Present and Future Analysis

for Physician Dispensed Cosmeceuticals by Product Segment-

Eyelash Products and Skin Care Products Independently

Analyzed with Annual Sales Figures in US$ Million for the

Years 2010 through 2018 (includes corresponding Graph/Chart) III-30

Table 31: Chinese Historic Review for Physician DispensedCosmeceuticals by Product Segment- Eyelash Products and SkinCare Products Independently Analyzed with Annual SalesFigures in US$ Million for the Years 2004 through 2009(includes corresponding Graph/Chart) III-31

Table 32: Chinese 15-Year Perspective for Physician

Dispensed Cosmeceuticals by Product Segment - Percentage

Breakdown of Value Sales for Eyelash Products and Skin Care

Products for the Years 2004, 2011 and 2018 (includes

corresponding Graph/Chart) III-32

5b. INDIA III-33Market Analysis III-33Table 33: Indian Recent Past, Present and Future Analysisfor Physician Dispensed Cosmeceuticals by Product Segment-Eyelash Products and Skin Care Products IndependentlyAnalyzed with Annual Sales Figures in US$ Million for theYears 2010 through 2018 (includes corresponding Graph/Chart) III-33

Table 34: Indian Historic Review for Physician Dispensed

Cosmeceuticals by Product Segment- Eyelash Products and Skin

Care Products Independently Analyzed with Annual Sales

Figures in US$ Million for the Years 2004 through 2009

(includes corresponding Graph/Chart) III-34

Table 35: Indian 15-Year Perspective for Physician DispensedCosmeceuticals by Product Segment - Percentage Breakdown ofValue Sales for - Eyelash Products and Skin Care Productsfor the Years 2004, 2011 and 2018 (includes correspondingGraph/Chart) III-35

5c. REST OF ASIA-PACIFIC III-36

A.Market Analysis III-36

Outlook III-36

B.Market Analytics III-36

Table 36: Rest of Asia-Pacific Recent Past, Present and

Future Analysis for Physician Dispensed Cosmeceuticals by

Product Segment- Eyelash Products and Skin Care Products

Independently Analyzed with Annual Sales Figures in US$

Million for the Years 2010 through 2018 (includes

corresponding Graph/Chart) III-36

Table 37: Rest of Asia-Pacific Historic Review for PhysicianDispensed Cosmeceuticals by Product Segment- EyelashProducts and Skin Care Products Independently Analyzed withAnnual Sales Figures in US$ Million for the Years 2004through 2009 (includes corresponding Graph/Chart) III-37

Table 38: Rest of Asia-Pacific 15-Year Perspective for

Physician Dispensed Cosmeceuticals by Product Segment -

Percentage Breakdown of Value Sales for Eyelash Products and

Skin Care Products for the Years 2004, 2011 and 2018

(includes corresponding Graph/Chart) III-38

6. LATIN AMERICA III-39Market Analysis III-39Table 39: Latin America Recent Past, Present and FutureAnalysis for Physician Dispensed Cosmeceuticals byGeographic Region - Brazil, Mexico and Rest of Latin AmericaMarkets Independently Analyzed with Annual Sales Figures inUS$ Million for the Years 2010 through 2018 (includescorresponding Graph/Chart) III-40

Table 40: Latin America Historic Review for Physician

Dispensed Cosmeceuticals by Geographic Region - Brazil,

Mexico and Rest of Latin America Markets Independently

Analyzed with Annual Sales Figures in US$ Million for the

Years 2004 through 2009 (includes corresponding Graph/Chart) III-41

Table 41: Latin America Recent Past, Present and FutureAnalysis for Physician Dispensed Cosmeceuticals by ProductSegment- Eyelash Products and Skin Care ProductsIndependently Analyzed with Annual Sales Figures in US$Million for the Years 2010 through 2018 (includescorresponding Graph/Chart) III-42

Table 42: Latin America Historic Review for Physician

Dispensed Cosmeceuticals by Product Segment- Eyelash

Products and Skin Care Products Independently Analyzed with

Annual Sales Figures in US$ Million for the Years 2004

through 2009 (includes corresponding Graph/Chart) III-43

Table 43: Latin America 15-Year Perspective for PhysicianDispensed Cosmeceuticals by Geographic Region - PercentageBreakdown of Value Sales for - Brazil, Mexico and Rest ofLatin America Markets for the Years 2004, 2011 and 2018(includes corresponding Graph/Chart) III-44

Table 44: Latin America 15-Year Perspective for Physician

Dispensed Cosmeceuticals by Product Segment - Percentage

Breakdown of Value Sales for Eyelash Products and Skin Care

Products for the Years 2004, 2011 and 2018 (includes

corresponding Graph/Chart) III-45

6a. BRAZIL III-46A.Market Analysis III-46Outlook III-46B.Market Analytics III-46Table 45: Brazilian Recent Past, Present and Future Analysisfor Physician Dispensed Cosmeceuticals by Product Segment-Eyelash Products and Skin Care Products IndependentlyAnalyzed with Annual Sales Figures in US$ Million for theYears 2010 through 2018 (includes corresponding Graph/Chart) III-46

Table 46: Brazilian Historic Review for Physician Dispensed

Cosmeceuticals by Product Segment- Eyelash Products and Skin

Care Products Independently Analyzed with Annual Sales

Figures in US$ Million for the Years 2004 through 2009

(includes corresponding Graph/Chart) III-47

Table 47: Brazilian 15-Year Perspective for PhysicianDispensed Cosmeceuticals by Product Segment - PercentageBreakdown of Value Sales for Eyelash Products and Skin CareProducts for the Years 2004, 2011 and 2018 (includescorresponding Graph/Chart) III-48

6b. MEXICO III-49

A.Market Analysis III-49

Outlook III-49

B.Market Analytics III-49

Table 48: Mexican Recent Past, Present and Future Analysis

for Physician Dispensed Cosmeceuticals by Product Segment-

Eyelash Products and Skin Care Products Independently

Analyzed with Annual Sales Figures in US$ Million for the

Years 2010 through 2018 (includes corresponding Graph/Chart) III-49

Table 49: Mexican Historic Review for Physician DispensedCosmeceuticals by Product Segment- Eyelash Products and SkinCare Products Independently Analyzed with Annual SalesFigures in US$ Million for the Years 2004 through 2009(includes corresponding Graph/Chart) III-50

Table 50: Mexican 15-Year Perspective for Physician

Dispensed Cosmeceuticals by Product Segment - Percentage

Breakdown of Value Sales for Eyelash Products and Skin Care

Products for the Years 2004, 2011 and 2018 (includes

corresponding Graph/Chart) III-51

6c. REST OF LATIN AMERICA III-52Market Analysis III-52Table 51: Rest of Latin America Recent Past, Present andFuture Analysis for Physician Dispensed Cosmeceuticals byProduct Segment- Eyelash Products and Skin Care ProductsIndependently Analyzed with Annual Sales Figures in US$Million for the Years 2010 through 2018 (includescorresponding Graph/Chart) III-52

Table 52: Rest of Latin America Historic Review for

Physician Dispensed Cosmeceuticals by Product Segment-

Eyelash Products and Skin Care Products Independently

Analyzed with Annual Sales Figures in US$ Million for the

Years 2004 through 2009 (includes corresponding Graph/Chart) III-53

Table 53: Rest of Latin America 15-Year Perspective forPhysician Dispensed Cosmeceuticals by Product Segment -Percentage Breakdown of Value Sales for Eyelash Products andSkin Care Products for the Years 2004, 2011 and 2018(includes corresponding Graph/Chart) III-54

7. REST OF WORLD III-55

Market Analysis III-55

Table 54: Rest of World Recent Past, Present and Future

Analysis for Physician Dispensed Cosmeceuticals by Product

Segment- Eyelash Products and Skin Care Products

Independently Analyzed with Annual Sales Figures in US$

Million for the Years 2010 through 2018 (includes

corresponding Graph/Chart) III-55

Table 55: Rest of World Historic Review for PhysicianDispensed Cosmeceuticals by Product Segment- EyelashProducts and Skin Care Products Independently Analyzed withAnnual Sales Figures in US$ Million for the Years 2004through 2009 (includes corresponding Graph/Chart) III-56

Table 56: Rest of World 15-Year Perspective for Physician

Dispensed Cosmeceuticals by Product Segment - Percentage

Breakdown of Value Sales for Eyelash Products and Skin Care

Products for the Years 2004, 2011 and 2018 (includes

corresponding Graph/Chart) III-57

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 73 (including Divisions/Subsidiaries - 80)

The United States (64)Canada (3)Europe (10)- France (9)- Rest of Europe (1)Asia-Pacific (Excluding Japan)(1)Africa (1)Middle East (1)

To order this report: Skin_Care_Products Industry : Global Physician Dispensed Cosmeceuticals Industry

Nicolas Bombourg

Reportlinker

Email: nicolasbombourg@reportlinker.com

US: (805)652-2626

Intl: +1 805-652-2626

SOURCE Reportlinker
COPYRIGHT 2012 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2012 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Geographic Code:90ASI
Date:Sep 6, 2012
Words:3835
Previous Article:All-American Dads From Utah, THE PIANO GUYS, Team Up With Sony Masterworks To Take Their Online Fame To The Next Level.
Next Article:Global Legal Process Outsourcing (LPO) Industry.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters